Olga Stehlíková

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Andy C. Rawstron, Claudia Fazi, Andreas Agathangelidis et al. · Leukemia · 2015 · 241 citations · Full text

Medicine, Hematology, Oncology +17

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

Andy C. Rawstron, Karl‐Anton Kreuzer, Asha Soosapilla et al. · Cytometry Part B Clinical Cytometry · 2017 · 198 citations · Full text

Medicine, Hematology, Pathology +17

Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia

Pavlína Janovská, Lucie Poppová, Karla Plevová et al. · Clinical Cancer Research · 2015 · 55 citations

Medicine, Hematology, Oncology +15

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

Richard Greil, Petra Obrtlíková, Lukáš Smolej et al. · The Lancet Haematology · 2016 · 46 citations

Medicine, Hematology, Immunology +11

Intra‐ and interlaboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 Practical Guidelines for high‐sensitivity paroxysmal nocturnal hemoglobinuria testing

Iuri Marinov, Martina Kohoutová, Vlasta Tkáčová et al. · Cytometry Part B Clinical Cytometry · 2013 · 28 citations · Full text

Medicine, Hematology, Hematology Physiology +12